# Neutropenia and Cancer Infections

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/neutropenia-and-cancer-infections/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the management of febrile neutropenia in cancer patients, particularly those with hematological malignancies receiving chemotherapy. It includes clinical practice guidelines, updates on antimicrobial agents, use of granulocyte colony-stimulating factor, risk assessment tools, prophylactic strategies, and the impact of febrile neutropenia on morbidity and mortality. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t12172 |
| Works | 137 |

## Topic papers all

Showing 15 of 137.

- [Chronic Health Conditions in Adult Survivors of Childhood Cancer](https://scholariq.org/papers/chronic-health-conditions-in-adult-survivors-of-childhood-cancer/)
- [Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial](https://scholariq.org/papers/symptom-monitoring-with-patient-reported-outcomes-during-routine-cancer/)
- [Topoisomerase I inhibitors: camptothecins and beyond](https://scholariq.org/papers/topoisomerase-i-inhibitors-camptothecins-and-beyond/)
- [DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs](https://scholariq.org/papers/dna-topoisomerases-and-their-poisoning-by-anticancer-and-antibacterial-drugs/)
- [2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline](https://scholariq.org/papers/2006-update-of-recommendations-for-the-use-of-white-blood-cell-growth-factors-an/)
- [A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow Transplantation](https://scholariq.org/papers/a-controlled-trial-of-fluconazole-to-prevent-fungal-infections-in-patients/)
- [Patients' Expectations about Effects of Chemotherapy for Advanced Cancer](https://scholariq.org/papers/patients-expectations-about-effects-of-chemotherapy-for-advanced-cancer/)
- [2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines](https://scholariq.org/papers/2000-update-of-recommendations-for-the-use-of-hematopoietic-colony-stimulating/)
- [Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia](https://scholariq.org/papers/caspofungin-versus-liposomal-amphotericin-b-for-empirical-antifungal-therapy-in/)
- [Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update](https://scholariq.org/papers/recommendations-for-the-use-of-wbc-growth-factors-american-society-of-clinical/)
- [American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer](https://scholariq.org/papers/american-society-of-hematology-2021-guidelines-for-management-of-venous/)
- [Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events](https://scholariq.org/papers/society-for-immunotherapy-of-cancer-sitc-clinical-practice-guideline-on-immune/)
- [Drugging Topoisomerases: Lessons and Challenges](https://scholariq.org/papers/drugging-topoisomerases-lessons-and-challenges/)
- [Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/acute-myeloid-leukemia-version-3-2017-nccn-clinical-practice-guidelines-in/)
- [Outcomes of Critically Ill Patients With Hematologic Malignancies: Prospective Multicenter Data From France and Belgium—A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study](https://scholariq.org/papers/outcomes-of-critically-ill-patients-with-hematologic-malignancies-prospective/)

## Topic primary papers

Showing 15 of 36.

- [2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline](https://scholariq.org/papers/2006-update-of-recommendations-for-the-use-of-white-blood-cell-growth-factors-an/)
- [2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines](https://scholariq.org/papers/2000-update-of-recommendations-for-the-use-of-hematopoietic-colony-stimulating/)
- [Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update](https://scholariq.org/papers/recommendations-for-the-use-of-wbc-growth-factors-american-society-of-clinical/)
- [Outcomes of Critically Ill Patients With Hematologic Malignancies: Prospective Multicenter Data From France and Belgium—A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study](https://scholariq.org/papers/outcomes-of-critically-ill-patients-with-hematologic-malignancies-prospective/)
- [Granulocyte–Macrophage Colony-Stimulating Factor after Initial Chemotherapy for Elderly Patients with Primary Acute Myelogenous Leukemia](https://scholariq.org/papers/granulocyte-macrophage-colony-stimulating-factor-after-initial-chemotherapy-for/)
- [Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance](https://scholariq.org/papers/recent-changes-in-bacteremia-in-patients-with-cancer-a-systematic-review-of/)
- [A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy.](https://scholariq.org/papers/a-randomized-placebo-controlled-trial-of-recombinant-human-interleukin-11-in/)
- [Acute Myeloid Leukemia or Myelodysplastic Syndrome Following Use of Granulocyte Colony-Stimulating Factors During Breast Cancer Adjuvant Chemotherapy](https://scholariq.org/papers/acute-myeloid-leukemia-or-myelodysplastic-syndrome-following-use-of-granulocyte/)
- [Randomized Placebo‐Controlled Trial of Fluconazole Prophylaxis for Neutropenic Cancer Patients: Benefit Based on Purpose and Intensity of Cytotoxic Therapy](https://scholariq.org/papers/randomized-placebo-controlled-trial-of-fluconazole-prophylaxis-for-neutropenic/)
- [Risk of Secondary Leukemia After a Solid Tumor in Childhood According to the Dose of Epipodophyllotoxins and Anthracyclines: A Case-Control Study by the Société Française d’Oncologie Pédiatrique](https://scholariq.org/papers/risk-of-secondary-leukemia-after-a-solid-tumor-in-childhood-according-to-the/)
- [Filgrastim in Patients with Chemotherapy-Induced Febrile Neutropenia: A Double-Blind, Placebo-Controlled Trial](https://scholariq.org/papers/filgrastim-in-patients-with-chemotherapy-induced-febrile-neutropenia-a-double/)
- [Prompt administration of antibiotics is associated with improved outcomes in febrile neutropenia in children with cancer](https://scholariq.org/papers/prompt-administration-of-antibiotics-is-associated-with-improved-outcomes-in/)
- [The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials](https://scholariq.org/papers/the-impact-of-primary-prophylaxis-with-granulocyte-colony-stimulating-factors-on/)
- [Current management of chemotherapy-induced neutropenia in adults: key points and new challenges](https://scholariq.org/papers/current-management-of-chemotherapy-induced-neutropenia-in-adults-key-points-and/)
- [Pediatric patients who receive antibiotics for fever and neutropenia in less than 60 min have decreased intensive care needs](https://scholariq.org/papers/pediatric-patients-who-receive-antibiotics-for-fever-and-neutropenia-in-less/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.